Foundation for Women's Cancer – Trademark Portfolio
Entity Type: 99
Foundation for Women's Cancer holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 2 Nice Classification classes. Currently, 3 trademarks are registered and 1 is pending. Notable registered marks include MOVE THE MESSAGE and FOUNDATION FOR WOMEN'S CANCER. The owner is based in Chicago, IL.
230 W Monroe St #710
Chicago, IL 60606
Showing of trademarks Trademarks
Trademark Classifications
Foundation for Women's Cancer's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Frequently Asked Questions
How many trademarks does Foundation for Women's Cancer have?
Foundation for Women's Cancer has 4 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 pending.
What trademark classes does Foundation for Women's Cancer file in?
Foundation for Women's Cancer files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial). Class 35 covers advertising; business management; business administration; office functions.
What are Foundation for Women's Cancer's most well-known trademarks?
Foundation for Women's Cancer's registered trademark portfolio includes well-known marks such as MOVE THE MESSAGE and FOUNDATION FOR WOMEN'S CANCER. These are among 3 currently registered trademarks in the portfolio.
What is Foundation for Women's Cancer's trademark registration success rate?
Foundation for Women's Cancer has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 1 application is pending review.